8.90
price up icon0.45%   0.04
after-market 시간 외 거래: 8.90
loading
전일 마감가:
$8.86
열려 있는:
$8.81
하루 거래량:
283.90K
Relative Volume:
1.00
시가총액:
$596.09M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-14.83
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
+5.08%
1개월 성능:
+10.15%
6개월 성능:
+22.25%
1년 성능:
-17.59%
1일 변동 폭
Value
$8.63
$8.95
1주일 범위
Value
$8.11
$9.53
52주 변동 폭
Value
$5.81
$10.84

Bioventus Inc Stock (BVS) Company Profile

Name
명칭
Bioventus Inc
Name
전화
(919) 474-6700
Name
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
직원
950
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
BVS's Discussions on Twitter

Compare BVS vs ABT, SYK, MDT, BSX, EW

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
BVS
Bioventus Inc
8.90 593.41M 555.06M -39.48M 29.05M -0.60
Medical Devices icon
ABT
Abbott Laboratories
110.25 192.10B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
345.78 137.25B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
88.97 115.41B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
69.63 103.81B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
85.09 49.82B 6.07B 1.06B 1.34B 1.8063

Bioventus Inc Stock (BVS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-02-09 개시 Barrington Research Outperform
2025-07-07 개시 Cantor Fitzgerald Overweight
2024-12-17 업그레이드 JP Morgan Underweight → Neutral
2023-12-07 업그레이드 Canaccord Genuity Hold → Buy
2023-08-09 업그레이드 Craig Hallum Hold → Buy
2022-11-22 다운그레이드 Craig Hallum Buy → Hold
2022-11-09 다운그레이드 Canaccord Genuity Buy → Hold
2022-11-09 다운그레이드 JP Morgan Overweight → Underweight
2022-03-15 개시 Craig Hallum Buy
2021-11-15 재개 Morgan Stanley Overweight
2021-11-10 재개 JP Morgan Overweight
2021-07-01 다운그레이드 Goldman Buy → Neutral
2021-03-08 개시 Canaccord Genuity Buy
2021-03-08 개시 Goldman Buy
2021-03-08 개시 JP Morgan Overweight
2021-03-08 개시 Morgan Stanley Overweight
모두보기

Bioventus Inc 주식(BVS)의 최신 뉴스

pulisher
Mar 09, 2026

Earnings call transcript: Bioventus Inc. Q4 2025 beats EPS estimates, stock surges - Investing.com Nigeria

Mar 09, 2026
pulisher
Mar 09, 2026

Bioventus Earnings Call Signals Profitable Growth Ahead - TipRanks

Mar 09, 2026
pulisher
Mar 09, 2026

Bioventus Inc. (NASDAQ:BVS) Q4 2025 earnings call transcript - MSN

Mar 09, 2026
pulisher
Mar 08, 2026

Momentum Shift: How is Bioventus Inc managing supply chain issues2026 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - baoquankhu1.vn

Mar 08, 2026
pulisher
Mar 06, 2026

Risks Report: Is Bioventus Inc exposed to currency risksJuly 2025 Chart Watch & Growth Focused Stock Pick Reports - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Craig-Hallum Maintains Buy on Bioventus Inc (BVS) March 2026, PT $16 - Meyka

Mar 06, 2026
pulisher
Mar 06, 2026

Aug Action: Will Bioventus Inc benefit from rising consumer demandProduct Launch & Technical Pattern Alert System - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus (NYSE:BVS) In Focus as NYSE Composite Tracks MedTech Moves - Kalkine Media

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus (BVS) Receives Updated Price Target from Barrington Re - GuruFocus

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus (NYSE:BVS) Stock Price Expected to Rise, Barrington Research Analyst Says - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus (NASDAQ:BVS) Shares Down 8.2%Here's Why - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus (NYSE:BVS) Given New $16.00 Price Target at Craig Hallum - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Craig-Hallum raises Bioventus stock price target on guidance beat By Investing.com - Investing.com India

Mar 06, 2026
pulisher
Mar 06, 2026

Craig-Hallum raises Bioventus stock price target on guidance beat - Investing.com South Africa

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus Inc. (NASDAQ:BVS) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus: Q4 Earnings Snapshot - theheraldreview.com

Mar 06, 2026
pulisher
Mar 06, 2026

Bioventus earnings beat by $0.04, revenue topped estimates - Investing.com Australia

Mar 06, 2026
pulisher
Mar 05, 2026

BVS Targets Revenue Range of $600M-$610M for FY26 - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Q4 Earnings Call Highlights - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Inc (BVS) Q4 2025 Earnings Call Highlights: Strong Org - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus (NYSE:BVS) Shares Gap UpHere's Why - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Shares Rise After Analyst Upgrade - National Today

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus (NASDAQ:BVS) Shares Gap Up After Analyst Upgrade - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus (BVS) Q4 2025 Earnings Call Transcript - AOL.com

Mar 05, 2026
pulisher
Mar 05, 2026

Earnings call transcript: Bioventus Inc. Q4 2025 beats EPS estimates, stock surges By Investing.com - Investing.com South Africa

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus (NASDAQ:BVS) Rating Increased to Strong-Buy at Cantor Fitzgerald - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus shares jump 7.6% on fourth-quarter earnings beat By Investing.com - Investing.com Canada

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus shares jump 7.6% on fourth-quarter earnings beat - Investing.com Australia

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus beats Q4 estimates, guides 2026 revenue in line By Investing.com - Investing.com Australia

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Q4 2025 Earnings Call Transcript - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus 10-K: $568.1M Revenue, $0.33 Diluted EPS - TradingView

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus (BVS) Exceeds Q4 Revenue Expectations, Eyes Future Gro - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Q4 and Full Year 2025 Financial Results - TradingView

Mar 05, 2026
pulisher
Mar 05, 2026

BIOVENTUS ($BVS) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus beats Q4 estimates, guides 2026 revenue in line - Investing.com India

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus (NYSE:BVS) Updates FY 2026 Earnings Guidance - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Q4 Earnings Assessment - Benzinga

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus beats Q4 revenue estimates on strong demand for pain treatments and surgical solutions - TradingView

Mar 05, 2026
pulisher
Mar 05, 2026

Bioventus Earnings Report: Q4 Overview - Benzinga

Mar 05, 2026
pulisher
Mar 04, 2026

BVS SEC FilingsBioventus Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Technical Analysis: Will Bioventus Inc benefit from rising consumer demandProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

Preview: Bioventus's Earnings - Benzinga

Mar 04, 2026
pulisher
Mar 04, 2026

Bioventus Inc. $BVS Shares Bought by Royce & Associates LP - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Bioventus (BVS) versus Its Peers Critical Comparison - Defense World

Mar 04, 2026
pulisher
Mar 03, 2026

Bioventus (NYSE:BVS) Stock Price Down 0.1%Should You Sell? - MarketBeat

Mar 03, 2026
pulisher
Feb 27, 2026

Bioventus Inc. (BVS) Stock Analysis: Unpacking A 63.66% Potential Upside - DirectorsTalk Interviews

Feb 27, 2026
pulisher
Feb 26, 2026

Reviewing Bioventus (BVS) and Its Peers - Defense World

Feb 26, 2026
pulisher
Feb 25, 2026

Iovance Surged 44% This Week and Its Philadelphia Factory Explains Why - AOL.com

Feb 25, 2026
pulisher
Feb 25, 2026

Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 - The Manila Times

Feb 25, 2026

Bioventus Inc (BVS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices ZBH
$93.73
price up icon 2.21%
medical_devices STE
$221.55
price down icon 0.24%
$66.31
price down icon 2.18%
medical_devices PHG
$28.81
price down icon 0.48%
$72.65
price down icon 0.11%
medical_devices EW
$85.09
price down icon 0.80%
자본화:     |  볼륨(24시간):